No Data
No Data
Viking Therapeutics Participates in a Conference Call With Maxim Group
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $118
Viking Therapeutics | 10-Q: Q1 2025 Earnings Report
Viking Therapeutics Insiders Sold US$21m Of Shares Suggesting Hesitancy
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025
Viking Therapeutics Price Target Cut to $102.00/Share From $105.00 by Morgan Stanley